THOMAS VERTREES: Open Payments
NPI 1356524839 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 61 payments from 11 companies in 2025. Trend: 2023 $389 · 2024 $1,404 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 11 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $176 |
| Collegium Pharmaceutical, Inc. | 12 | $157 |
| Alkermes, Inc. | 4 | $97 |
| Axsome Therapeutics, Inc. | 5 | $84 |
| Noven Therapeutics, LLC | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
Products named: Azstarys, CAPLYTA, Jornay PM, Auvelity, Xelstrym, SPRAVATO, REXULTI, VRAYLAR.
Industry payments across TN — which companies pay providers there.
